Ariad patent victory over Lilly among largest in 2006

Eli Lilly and Co.’s loss in May of a patent-infringement lawsuit brought by Ariad Pharmaceuticals
Inc. went down as the 6th-largest such jury award last year, a Bloomberg analysis shows.

A Massachusetts jury awarded Ariad $65.2 million after unanimously agreeing that Lilly’s Evista and Xigris drugs infringed
on a patent held by the Cambridge, Mass., drug developer.

 
Jury awards for patent verdicts nearly tripled last year from 2005—to $1 billion—as
companies took to the courts to protect valuable technology, and increasingly trusted juries to sort through complex disagreements.
 
The largest jury award last year for infringing a patent, $307 million, went to Los Altos,
Calif.-based Rambus Inc. after it sued Hynix Semiconductor Inc. of Inchon, South Korea, over use of random access memory.
A judge cut the figure to $133.4 million.

Please enable JavaScript to view this content.

Story Continues Below

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our updated comment policy that will govern how comments are moderated.

{{ articles_remaining }}
Free {{ article_text }} Remaining
{{ articles_remaining }}
Free {{ article_text }} Remaining Article limit resets on
{{ count_down }}